Although contrast agents have an essential role in non-invasive imaging techniques, potential side effects limit their use. For example, both low- and iso-osmolar iodinated contrast media used in ...

In a new pilot feasibility study, researchers from Mayo Clinic, the University of Washington School of Medicine, the ...

ACA Pharma: [email protected] Azurity Pharmaceuticals: [email protected] ...

Las Vegas, NV / Syndication Cloud / January 23, 2026 / ContrastConnect The American College of Radiology (ACR) and the ...

Researchers from the University of Washington School of Medicine in Seattle, Mayo Clinic in Rochester, Minn., the University ...

A new magnetic resonance imaging (MRI) contrast agent being tested by researchers at Case Western Reserve University not only pinpoints breast cancers at early stages but differentiates between ...

April 13, 2007 (New York, NY) - A new type of iodine-based contrast agent that interacts with activated macrophages may one day be used in humans during multislice computed tomography to identify ...

CHICAGO--(BUSINESS WIRE)--Ultrasound contrast agents show promise for detecting and evaluating uterine disorders and prostate cancers, scientists reported today at the annual Advances in Contrast ...

BERLIN--(BUSINESS WIRE)--Bayer, a global leader in radiology, today announced positive topline results of the pivotal Phase III QUANTI studies evaluating the efficacy and safety of gadoquatrane, an ...

The recommendation is included in the organization’s “Guidelines for the management of chronic coronary syndromes,” published Aug. 30 in the European Heart Journal. “Ultrasound contrast agents ...

BR55 was safe and highly accurate (>95%) at marking VEGFR2 expression in patients with breast, ovarian and thyroid cancer, as well as Crohn disease. The Food and Drug Administration (FDA) has granted ...